BioSpace News Archive

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the TD Cowen Radiopharmaceutical Innovation Summit on Tuesday, June 20, 2023 at 11:30 a.m. ET.

Bio-Thera Solutions, Ltd announced the company has entered into a licensing and supply agreement with Biomm SA, for BAT2206, its ustekinumab biosimilar, under which Biomm will have exclusive rights to distribute and market the drug in Brazil.

RaySearch Laboratories AB announces that the Australian Bragg Centre for Proton Therapy and Research in Adelaide, Australia has placed an order for the oncology information system RayCare®*.

Microbot Medical Inc. is encouraged by the continued participation and level of enthusiasm being demonstrated by the Key Opinion Leaders globally who are using the LIBERTY® Robotic Surgical System during the Company’s pre-clinical animal studies.

Moss Genomics Inc. (CSE: MOSS) (“Moss” or the “Company”), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its diet and vitamin reports (the “Reports”) which can be ordered directly to your home via our online platform.

PharmAla Biotech Holdings Inc. is pleased to announce the receipt of an export permit for the shipment of its allotment of GMP LaNeo MDMA to the University of Sydney.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced preclinical data from six presentations, including two oral presentations, at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting.

SeekIn Inc announced that a research article titled “A panel of seven protein tumor markers for effective and affordable multicancer early detection by artificial intelligence” has been published in eClinicalMedicine, a clinical journal published by The Lancet.

The International Niemann-Pick Disease Registry (INPDR) and biopharmaceutical company Mandos Health today announce a new collaboration giving Mandos Health controlled access to registry information via INPDR’s research “Gateway” platform.

Tenon Medical, Inc. (“Tenon” or the “Company”) (NASDAQ:TNON), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced the closing of its public offering of 10,000,000 units, with each unit consisting of one share of common stock and two warrants, each warrant to purchase one share of common stock.